Quote:

---

I still do not understand why we are dosing half of the patients, in the current trial, at 350mg.

---

Under the old FDA they thought that leronlimab was an immunosuppressant and were bewildered why Cytodyn would consider it for anything outside HIV. Under the new FDA they probably think using it will lead to autism.